RRML - Emergence of Carbapenemase-producing Enterobacteriaceae, a Public Health Threat: a Romanian Infectious Disease Hospital Based Study
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2019): 0.945

Rejection rate (2016): 55%

Română English


Clarivate analytics (ISI) Impact factor


Advanced search


Top 10 downloaded articles
- August 2020 -
 
Romanian Review of Laboratory ... 8
Metabolomic biomarkers of poly... 6
Mucopolysaccharidosis type I -... 4
Carbapenemase Producing Entero... 3
Total Errors of TSH results by... 3
High frequency of BRCA recurre... 3
Evaluation of Diagnostic Tests... 2
Plasma levels of resistin pred... 2
Multiplex ligation dependent p... 2
The usefulness of neutrophil/l... 2

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 23(3)/2015 DOI:10.1515/rrlm-2015-0024
XML
TXT

Emergence of Carbapenemase-producing Enterobacteriaceae, a Public Health Threat: a Romanian Infectious Disease Hospital Based Study

Alexandru Rafila, Daniela Talapan, Olga Mihaela Dorobăţ, Gabriel Adrian Popescu, Daniela Piţigoi, Dragoş Florea, Florin Corneliu Buicu


Abstract:

Introduction: Hospital-acquired infections caused by Enterobacteriaceae producing different types of carbapenem-hydrolizing enzymes are now commonly observed and represent a great limitation for antimicrobial therapy. The purpose of the study was to evaluate the emergence of carbapenem-resistant Enterobaceriaceae among the strains isolated from hospitalized patients to the National Institute of Infectious Diseases, Bucharest (NIID) and the identification of different types of carbapenemases, using phenotypic methods. Materials and methods: Between January - June 2014, 587 strains of Klebsiella pneumoniae, Enterobacter species and E.coli were isolated from various clinical specimens. We were included all non-susceptible strains to carbapenems, according to EUCAST 2014 clinical breakpoints, as determined by using microdilution MicroScan Panels (Siemens Healthcare Diagnostics). The modified Hodge test (MHT) was performed as phenotypic confirmatory test for carbapenemase production according to CLSI guidelines and the combination disk test (KPC, MBL , OXA-48 Confirm kit, Rosco Diagnostica) according to EUCAST guidelines. Results: A total of 45 non-repeat Enterobaceriaceae (32 strains Klebsiella pneumoniae, 5 strains E.coli, 8 strains Enterobacter spp) were identified as non-susceptibile to one or more carbapenems (93,33% ertapenem, 53,33% meropenem, 48,88% imipenem). Most strains were isolated from urine (75,55%). MHT was positive in 55,6% (25/45) of carbapenem-resistant strains; in 24 cases the carbapenem-hydrolizing enzyme was identified as: OXA-48-like (n=16), KPC (n=4), MBL (n=1), KPC + MBL (n=2) and MBL + OXA-48-like (n=1). All carbapenemase-positive strains were 100% resistant to 3rd and 4th generation cephalosporins, showing less resistance to tigecycline (12,5% resistant and 25% intermediate), colistin (37,5%) and fosfomycin (41,6%). Conclusion: During 6 months period, there were isolated 7,66% (45/587) carbapenem-resistant Enterobacteriaceae (K. pneumoniae 21,47%, E. coli 1,23%). Twenty four strains were carbapenemase-producers. The most frequent carbapenemase isolated in our study was OXA-48-like.

Keywords: Enterobacteriaceae, resistance, carbapenemase

Received: 12.3.2015
Accepted: 26.6.2015
Published: 12.7.2015

 
  PDF Download full text PDF
(514 KB)
     
 
How to cite
Rafila A, Talapan D, Dorobăţ OM, Popescu GA, Piţigoi D, Florea D, et al. Emergence of Carbapenemase-producing Enterobacteriaceae, a Public Health Threat: a Romanian Infectious Disease Hospital Based Study. Rev Romana Med Lab. 2015;23(3):295-301. DOI:10.1515/rrlm-2015-0024